Literature DB >> 32307202

Update on vasculitis: an overview and dermatological clues for clinical and histopathological diagnosis - part I.

Thâmara Cristiane Alves Batista Morita1, Gabriela Franco S Trés2, Roberta Fachini Jardim Criado3, Mirian Nacagami Sotto2, Paulo Ricardo Criado4.   

Abstract

The term vasculitis refers to the inflammation of vessel walls. It may range in severity from a self-limited disorder in one single organ to a life-threatening disease due to multiple organ failure. It has many causes, although they result in only a few histological patterns of vascular inflammation. Vessels of any type and in any organ can be affected, a fact that results in a broad variety of signs and symptoms. Different vasculitides with indistinguishable clinical presentations have quite different prognosis and treatments. This condition presents many challenges to physicians in terms of classification, diagnosis, appropriate laboratory workup, and treatment. Moreover, it compels a careful follow-up. This article reviews the Chapel-Hill 2012 classification, etiology, recent insights in pathophysiology, some important dermatological clues for the diagnosis and summarizes treatment of some of these complex vasculitis syndromes.
Copyright © 2020. Published by Elsevier España, S.L.U.

Entities:  

Keywords:  Anti-neutrophil cytoplasmic antibody-associated vasculitis; Classification; Diagnosis; Purpura; Systemic vasculitis; Vasculitis; Vasculitis, leukocytoclastic, cutaneous

Mesh:

Year:  2020        PMID: 32307202      PMCID: PMC7253914          DOI: 10.1016/j.abd.2020.01.003

Source DB:  PubMed          Journal:  An Bras Dermatol        ISSN: 0365-0596            Impact factor:   1.896


  36 in total

Review 1.  Vasculitis-What Do We Have to Know? A Review of Literature.

Authors:  Eran Shavit; Afsaneh Alavi; R Gary Sibbald
Journal:  Int J Low Extrem Wounds       Date:  2018-12-03       Impact factor: 2.057

Review 2.  Infection-associated vasculitides.

Authors:  Syed A Haq; Christian Pagnoux
Journal:  Int J Rheum Dis       Date:  2018-04-06       Impact factor: 2.454

3.  Incidence of leukocytoclastic vasculitis, 1996 to 2010: a population-based study in Olmsted County, Minnesota.

Authors:  Amrita Arora; David A Wetter; Tania M Gonzalez-Santiago; Mark D P Davis; Christine M Lohse
Journal:  Mayo Clin Proc       Date:  2014-06-27       Impact factor: 7.616

Review 4.  Pathogenesis of ANCA-associated vasculitis: An update.

Authors:  Pierre-André Jarrot; Gilles Kaplanski
Journal:  Autoimmun Rev       Date:  2016-03-09       Impact factor: 9.754

5.  Primary systemic vasculitis: clinical features and mortality.

Authors:  S E Lane; R A Watts; L Shepstone; D G I Scott
Journal:  QJM       Date:  2005-01-17

Review 6.  Vasculitis related to viral and other microbial agents.

Authors:  Gim Gee Teng; W Winn Chatham
Journal:  Best Pract Res Clin Rheumatol       Date:  2015-06-11       Impact factor: 4.098

7.  Drug-associated cutaneous vasculitis: study of 239 patients from a single referral center.

Authors:  Francisco Ortiz-Sanjuán; Ricardo Blanco; José L Hernández; Trinitario Pina; María C González-Vela; Héctor Fernández-Llaca; Vanesa Calvo-Río; Javier Loricera; Susana Armesto; Marcos A González-López; Javier Rueda-Gotor; Miguel A González-Gay
Journal:  J Rheumatol       Date:  2014-09-15       Impact factor: 4.666

Review 8.  An update of neurological manifestations of vasculitides and connective tissue diseases: a literature review.

Authors:  Anastasia Bougea; Evangelos Anagnostou; Nikolaos Spandideas; Nikolaos Triantafyllou; Evangelia Kararizou
Journal:  Einstein (Sao Paulo)       Date:  2015-08-21

Review 9.  Pathogenetic and Clinical Aspects of Anti-Neutrophil Cytoplasmic Autoantibody-Associated Vasculitides.

Authors:  Peter Lamprecht; Anja Kerstein; Sebastian Klapa; Susanne Schinke; Christian M Karsten; Xinhua Yu; Marc Ehlers; Jörg T Epplen; Konstanze Holl-Ulrich; Thorsten Wiech; Kathrin Kalies; Tanja Lange; Martin Laudien; Tamas Laskay; Timo Gemoll; Udo Schumacher; Sebastian Ullrich; Hauke Busch; Saleh Ibrahim; Nicole Fischer; Katrin Hasselbacher; Ralph Pries; Frank Petersen; Gesche Weppner; Rudolf Manz; Jens Y Humrich; Relana Nieberding; Gabriela Riemekasten; Antje Müller
Journal:  Front Immunol       Date:  2018-04-09       Impact factor: 7.561

10.  Circulating Level of Neutrophil Extracellular Traps Is Not a Useful Biomarker for Assessing Disease Activity in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.

Authors:  Huan Wang; Li-Li Sha; Tian-Tian Ma; Lu-Xia Zhang; Min Chen; Ming-Hui Zhao
Journal:  PLoS One       Date:  2016-02-03       Impact factor: 3.240

View more
  4 in total

1.  Drug-induced vasculitis: Thiazide or the COVID-19 vaccine, which one is guilty? A case report and literature review.

Authors:  Manoochehr Hekmat; Sepideh Jafari Naeini; Zahra Abbasi; Sahar Dadkhahfar
Journal:  Clin Case Rep       Date:  2022-06-13

2.  Immunologic markers, vasculitis-associated autoantibodies, and complement levels in patients with COVID-19.

Authors:  Maryam Mobini; Roya Ghasemian; Laleh Vahedi Larijani; Maede Mataji; Iradj Maleki
Journal:  J Res Med Sci       Date:  2021-10-18       Impact factor: 1.852

3.  Giant cell arteritis versus Takayasu's Arteritis: Two sides of the same coin?

Authors:  Peter W Mortensen; Subahari Raviskanthan; Patricia Chévez-Barrios; Andrew G Lee
Journal:  Saudi J Ophthalmol       Date:  2022-04-18

Review 4.  Cutaneous vasculitis; An algorithmic approach to diagnosis.

Authors:  Erkan Alpsoy
Journal:  Front Med (Lausanne)       Date:  2022-09-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.